Home/Specialty/Other/Coronavirus Antigen Detection Test System./Genabio COVID-19 Rapid Self-Test Kit

Genabio Diagnostics Inc. RA9-E00301 Genabio COVID-19 Rapid Self-Test Kit

Company Name

Genabio Diagnostics Inc.

Catalog Number

RA9-E00301

Have questions, or need more information? Contact Us

Pricing
Summary

Price Not Available

Out of Stock

Interested in this product?
Contact us or login to add to your watchlist.

Related Items

LUMIQUICK DIAGNOSTICS, INC. 1N40C5-1-US-BS Rapid SARS-CoV-2 Antigen Test Card

The Rapid SARS-CoV-2 Antigen Test Card is a single use rapid lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 and older, when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years and older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.

SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical

Genabio Diagnostics Inc. RA9-E00302 Genabio COVID-19 Rapid Self-Test Kit

Genabio Diagnostics Inc.

Genabio Diagnostics Inc. RA9-E00325 Genabio COVID-19 Rapid Self-Test Kit

SARS-CoV-2 antigen IVD, kit, fluorescent immunoassay, rapid

Genabio Diagnostics Inc. RA9-E00305 Genabio COVID-19 Rapid Self-Test Kit

Genabio Diagnostics Inc.

IHEALTH LAB INC. ICO-3000 iHealth

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

LUMIQUICK DIAGNOSTICS, INC. 1N40C5-1-US-BS Rapid SARS-CoV-2 Antigen Test Card

The Rapid SARS-CoV-2 Antigen Test Card is a single use rapid lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 and older, when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years and older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.

SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical

LUMIQUICK DIAGNOSTICS, INC. 1N40C5-1-US-BS Rapid SARS-CoV-2 Antigen Test Card

The Rapid SARS-CoV-2 Antigen Test Card is a single use rapid lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 and older, when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years and older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.

SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical

Additional Details

Device Identifier

00196852254316

Is RX

No

Is Over the Counter

Yes

Requires Sterilization

No

Is Sterile

No

Is Single Use

Yes

Categories

Barcode Mapping

Unit of Measurement	Eaches	GTIN
Each	1	00196852254316